Skip to main content

Table 3 Lipid profile

From: Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study

Variables

CAD (+) n = 140

CAD (−) n = 534

p value between the 2 groups

DM (+) n = 190

DM (−) n = 494

p value between the 2 groups

non-HDL-C (mg/dL)

123 ± 31

142 ± 3 5

< 0.0001

139 ± 35

134 ± 35

0.105

TG (mg/dL)*

128 (92/186)

120 (87/187)

0.295

139 (107/218)

119 (89/176)

< 0.0001

VLDL (%)

14.0 ± 6.9

12.6 ± 6.5

0.025

14.8 ± 6.8

12.2 ± 6.3

< 0.0001

RLP-C (mg/dL)*

5.0 (3.5/7.4)

5.4 (4.1/8.0)

0.130

5.7 (4.2/8.9)

5.2 (3.9/7.4)

0.0026

apo C-II (mg/dL)

4.7 ± 2.2

4.6 ± 2.1

0.627

4.7 (3.5/6.1)

4.2 (3.1/5.3)

0.0004

apo C-III (mg/dL)

10.2 ± 4.0

10.2 ± 3.7

0.856

9.7 (8.0/12.3)

9.4 (7.8/11.4)

0.059

LDL-C/apoB ratio*

1.174 (1.073/1.231)

1.241 (1.138/1.333)

< 0.0001

1.173 ± 0.152

1.227 ± 0.152

< 0.0001

TG/HDL-C ratio*

2.497 (1.715/3.824)

2.555 (1.360/3.593)

0.063

3.558 ± 2.648

2.828 ± 2.717

0.002

  1. TC total cholesterol, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglyceride, VLDL very LDL, RLP remnant-like particle, apo apolipoprotein, MDA malondealdehyde-modified, WBC white blood count, hs-CRP high-sensitivity C-reactive protein
  2. * Median; interquartile range in parentheses